Biomerica (BMRA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BMRA Biomerica

Watchlist

0.321
+0.007+2.23%

Close Nov 25 16:00 ET

0.312
-0.009-2.83%

Post 16:52 ET

5.40MMarket Cap-867P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Sector Update: Health Care Stocks Climb Thursday Afternoon
MT NewswiresNov 21 13:50 ET
Express News | Biomerica Inc: Patents Secured Apply to Countries Under European Patent Organization
ReutersNov 21 08:20 ET
Express News | Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis
ReutersNov 21 08:19 ET
Biomerica Secures Three Key International Patents for InFoods Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis
GlobeNewswireNov 21 08:19 ET
Express News | Nasdaq Grants Biomerica an Additional 180 Days to Meet Listing Compliance Requirements
ReutersNov 7 09:09 ET
12 Health Care Stocks Moving In Friday's After-Market Session
BenzingaNov 1 16:36 ET

Comments

Jaguar8

Nov 21 07:26

NEWS

$Biomerica (BMRA.US)$
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Biomerica (NASDAQ: BMRA) has secured three key patent allowances in European markets for its inFoods® Technology, targeting GERD, Crohn's Disease, and Ulcerative Colitis. The patents cover major European markets including Germany, UK, France, Italy, Spain, and over 30 other EPO nations. These markets represent significant opportunities: GERD ...

Trytosaveabit

Nov 21 07:20

News

$Biomerica (BMRA.US)$ Reuters
just
Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis